Search results
We will begin by analyzing cancer as a process, focusing on the current state of our knowledge on 4 specific aspects of its biology. Then, we will look at cancer as a global health problem, considering some epidemiological aspects, and discussing treatment, with a special focus on novel therapies.
14 sie 2023 · Overall, the cell cycle has many regulatory steps that are crucial to maintaining homeostasis inside of the cells during the replication of DNA and the division of cells. Mutation inside specific genes can lead to the loss of balance inside the cells, thus resulting in cancer growth.
10 paź 2023 · The cancer-immunity cycle provides a framework to understand the events that generate anti-cancer immune responses. Mellman, Chen, Powles, and Turley consider the last 10 years of research in cancer immunology and immunotherapy and review the progress in understanding each step of the cancer-immunity cycle, identifying challenges and ...
16 maj 2023 · In cells with nuclei, the cycle occurs in five stages: G0, in which the cell isn’t dividing but performs its normal work in the body. G1 (or gap1), in which the cell grows. S (or synthesis), in which it copies its DNA. G2 (or gap2), in which it prepares to divide.
10 paź 2023 · When cancer immunity is active, stimulation, proliferation, and functional killing of cancer cells is possible. However, inhibitory immune cells and stroma, metabolic derangements, and loss of T cell function can occur within the TME, halting the cancer-immunity cycle.
1 lut 2020 · Giant cell life cycle–mediated reprogramming is likely to account for the most commonly observed high-grade malignant tumors, including glioblastoma, triple-negative breast cancer, high-grade serous ovarian cancer, uterine serous carcinoma, pancreatic cancer, colon cancer, and high-grade sarcomas.
Everyone is at some risk of developing cancer. Cancer researchers use the term lifetime risk to indicate the probability that a person will develop cancer over the course of a lifetime. In the United States, men have a 1 in 2 lifetime risk of developing cancer, and women have a 1 in 3 risk.
